Despite advances in prevention and optimal medical therapy, coronary artery disease (CAD) remains the leading cause of morbidity and mortality throughout the world. Coronary artery revascularization in high-risk patients, such as those with acute coronary syndrome or stable ischemic heart disease with high-risk anatomy, is supported in current practice guidelines and appropriate use documents. Those who were deemed high risk or inoperable for coronary artery bypass grafting (CABG) were often relegated to medical therapy despite severe multivessel CAD. Similarly, this high-risk subset has often not been offered percutaneous coronary intervention (PCI) due to technical limitations or a perceived lack of benefit.
Advanced PCI techniques used during CHIP include rotational, orbital and laser, specialized antegrade and retrograde coronary artery chronic total occlusion (CTO) approaches and complex bifurcation stenting. After receiving CHIP, patients often experience dramatic improvement in symptoms, improved quality of life and less re-admissions to the hospital. We also include clinical subsets such as CHIP intervention in severe heart failure (HFrEF and valve disease (aortic stenosis and mitral regurgitation).
The goal of this Research Topic is:
1) To show long term results of CHIP interventions such as CTO, bifurcation, multivessel and left main PCI.
2) To highlight the importance of LVAD use in complex CHIP cases.
3) To update the current knowledge of technical aspect of complex CHIP PCI.
4) To gain exposure to CHIP-related complications and their management.
Potential topics include but are not limited to the following left main intervention, bifurcation intervention, chronic total occlusion recanalisation and multivessel disease intervention.
Despite advances in prevention and optimal medical therapy, coronary artery disease (CAD) remains the leading cause of morbidity and mortality throughout the world. Coronary artery revascularization in high-risk patients, such as those with acute coronary syndrome or stable ischemic heart disease with high-risk anatomy, is supported in current practice guidelines and appropriate use documents. Those who were deemed high risk or inoperable for coronary artery bypass grafting (CABG) were often relegated to medical therapy despite severe multivessel CAD. Similarly, this high-risk subset has often not been offered percutaneous coronary intervention (PCI) due to technical limitations or a perceived lack of benefit.
Advanced PCI techniques used during CHIP include rotational, orbital and laser, specialized antegrade and retrograde coronary artery chronic total occlusion (CTO) approaches and complex bifurcation stenting. After receiving CHIP, patients often experience dramatic improvement in symptoms, improved quality of life and less re-admissions to the hospital. We also include clinical subsets such as CHIP intervention in severe heart failure (HFrEF and valve disease (aortic stenosis and mitral regurgitation).
The goal of this Research Topic is:
1) To show long term results of CHIP interventions such as CTO, bifurcation, multivessel and left main PCI.
2) To highlight the importance of LVAD use in complex CHIP cases.
3) To update the current knowledge of technical aspect of complex CHIP PCI.
4) To gain exposure to CHIP-related complications and their management.
Potential topics include but are not limited to the following left main intervention, bifurcation intervention, chronic total occlusion recanalisation and multivessel disease intervention.